600812 华北制药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额550,8131,176,5391,229,5651,024,2671,004,391
投资活动产生之现金流量净额(161,260)(780,928)(946,732)(881,755)(528,465)
筹资活动产生之现金流量净额(838,372)(385,264)462,737(704,143)(4,478,604)
汇率变动对现金及现金等价物的影响(11,700)47711,82912,0688,438
现金及现金等价物净增加/(减少)(460,518)10,824757,399(549,563)(3,994,240)
期初现金及现金等价物余额1,273,2281,262,404505,0051,054,5685,048,808
期末现金及现金等价物余额812,7101,273,2281,262,404505,0051,054,568